Ipamorelin

DRUG2 trials

Sponsors

Helsinn Therapeutics (U.S.), Inc

Conditions

Gastrointestinal DysmotilityIleus

Phase 2

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

CompletedNCT00672074

Helsinn Therapeutics (U.S.), IncIleus

Start: 2008-04-30End: 2009-12-31Updated: 2017-04-14

Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

CompletedNCT01280344

Helsinn Therapeutics (U.S.), IncGastrointestinal Dysmotility

Start: 2011-04-30End: 2014-05-31Updated: 2017-04-13

Related Papers

Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.

2014-10-2117 citations